miR-497 is downregulated in colon cancer, which is capable of inhibiting cancer cell survival, proliferation, and invasion [13], by targeting IGF1R (insulin-like growth factor 1 receptor), an angiogenic activator that contributes to angiogenesis in tumors [14]. Here, IGF1R is linked to malignant colon neoplasm.